Dyslipidemias are common and increase the risk of cardiovascular disease. The menopause transition is associated with an atherogenic lipid profile. Published in Maturitas EMAS has produced an evidence-based clinical guide evaluating the effects on the lipid profile both of menopausal hormone therapy and of non-estrogen-based treatments for menopausal symptoms. Click here to read more.
Menopause symptom management in women with dyslipidemias: An EMAS clinical guide. Maturitas 2020; 135: 82–88.